Inspire Medical Systems, Inc.
INSP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $6 | $7 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $6 | $7 | $6 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 28.5% | 53.2% | 74.7% | – |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 84.7% | 84.5% | 83.8% | 85.7% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 8.1% | -2.7% | -10% | -16.5% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 6.7% | -3.4% | -11% | -18% |
| EPS Diluted | 1.75 | -0.72 | -1.6 | -1.54 |
| % Growth | 343.1% | 55% | -3.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |